Compare · CRKN vs TMO
CRKN vs TMO
Side-by-side comparison of Crown Electrokinetics Corp. (CRKN) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- CRKN operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $174.42B, about 4521.2x CRKN ($38.6M).
- Over the past year, CRKN is up 0.0% and TMO is up 15.8% - TMO leads by 15.8 points.
- TMO has hit the wire 6 times in the past 4 weeks while CRKN has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 1 for CRKN).
- Company
- Crown Electrokinetics Corp.
- Thermo Fisher Scientific Inc
- Price
- $1.82-46.78%
- $469.39-1.33%
- Market cap
- $38.6M
- $174.42B
- 1M return
- +0.00%
- +5.22%
- 1Y return
- +0.00%
- +15.83%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 6
- Recent ratings
- 1
- 25
Crown Electrokinetics Corp.
Crown Electrokinetics Corp. focuses on commercializing electrokinetic technology for use in the smart glass market. The company offers electrokinetic film technology for smart or dynamic glass. It develops and sells optical switching films. The company was formerly known as 3D Nanocolor Corp. and changed its name to Crown ElectroKinetics Corp. in October 2017. Crown ElectroKinetics Corp. was incorporated in 2015 and is based in Corvallis, Oregon.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest CRKN
- Crown Electrokinetics Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- Crown Electrokinetics Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
- Crown Fiber Optics Announces $100 Million in Secured Multi-Year Fiber Contracts
- Crown Electrokinetics Corp. filed SEC Form 8-K: Leadership Update
- Crown Electrokinetics Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant
- Crown Electrokinetics Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Crown Appoints Chris Robichaud to Board of Directors
- SEC Form NT 10-Q filed by Crown Electrokinetics Corp.
- SEC Form 25 filed by Crown Electrokinetics Corp.
- Crown Electrokinetics Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Latest TMO
- Piper Sandler initiated coverage on Thermo Fisher with a new price target
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)